Glaucoma Therapeutics Market by Product Type, Distribution Channel, End User 2024-2032

1
Global Glaucoma Therapeutics Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Glaucoma Therapeutics Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global glaucoma
  therapeutics market size reached US 7.9 Billion
  in 2023.
• Glaucoma is an ocular disorder that damages the
  optic nerve of the patient. The structural
  changes in the optic nerves are usually caused by
  the abnormally high intraocular pressure (IOP)
  due to the extra build-up of fluid in the front
  part of the eyes. This condition can often lead
  to vision loss and permanent blindness in
  progressive cases.
• Numerous medications and therapies are prescribed
  to patients with glaucoma in order to avoid
  complete vision loss. Eye drops that belong to
  the class of beta-blockers, alpha agonists,
  prostaglandins and cholinergic are usually
  prescribed to reduce the production of fluid in
  the eyes. These drops can then be followed by
  conventional or laser surgeries for effective
  results. In several cases, a combination of both
  approaches is utilized for the treatment of
  glaucoma.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/glaucoma-therapeutics-m
  arket/requestsample

4
Report Description

• Global Glaucoma Therapeutics Market Trends
• The market is primarily driven by the increasing
  occurrence of glaucoma on the global level. This
  can be attributed to the rising number of
  patients who have diabetes due to their shifting
  lifestyle patterns and a lack of physical
  activities. This, along with the increasing
  geriatric population that is more susceptible to
  chronic ocular disorders, is providing a thrust
  to the market growth. Along with this, there has
  been a growing preference for the adoption of
  laser glaucoma surgeries among the patients as
  well as the healthcare professionals on account
  of the successful outcomes of this procedure.
• Multiple professionals are also prescribing
  combination therapies for the treatment of
  glaucoma that involves the use of polymer-based
  contact lenses, drug-eluting punctal plugs,
  implantable extended-release devices,
  microneedle-injection devices and micro-dosing
  technologies. Coupled with the increasing number
  of awareness programs conducted by multiple
  organizations to spread awareness regarding the
  availability of effective glaucoma therapeutics,
  this is creating a positive outlook for the
  market. Some of the other factors contributing to
  the market growth include the continual research
  and development (RD) activities to introduce
  innovative therapeutics and the improving
  healthcare infrastructure across the globe,
  especially in developing economies.
• Looking forward, the market is expected to grow
  at a CAGR of 5.6 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/glaucoma-therapeutics-m
  arket

5
Report Segmentation

• Breakup by Drug Class
• Prostaglandin Analogs
• Beta Blockers
• Alpha Adrenergic Agonists
• Carbonic Anhydrase Inhibitors
• Combination Drugs
• Others
• Breakup by Indication
• Open Angle Glaucoma
• Angle Closure Glaucoma
• Others
• Breakup by End User
• Hospitals

6
Report Segmentation

• Ophthalmic Clinics
• Ambulatory Surgery Centers
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Aerie Pharmaceuticals Inc.
• Allergan Plc
• Bausch Lomb Incorporated (Bausch Health
  Companies Inc.)
• Inotek Pharmaceuticals Corp.
• Merck Co. Inc.
• Novartis AG
• Pfizer Inc.
• Santen Pharmaceutical Co. Ltd.
• SIFI S.p.A
• Teva Pharmaceutical Industries Ltd

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Glaucoma Therapeutics
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Drug Class    6.1  
   Prostaglandin Analogs        6.1.1 Market
  Trends        6.1.2 Market Forecast    6.2  
   Beta Blockers        6.2.1 Market Trends     
    6.2.2 Market Forecast    6.3    Alpha
  Adrenergic Agonists        6.3.1 Market Trends 
        6.3.2 Market Forecast       

10
Table of Contents

•     6.4    Carbonic Anhydrase Inhibitors       
  6.4.1 Market Trends        6.4.2 Market
  Forecast    6.5    Combination Drugs       
  6.5.1 Market Trends        6.5.2 Market
  Forecast    6.6    Others        6.6.1 Market
  Trends        6.6.2 Market Forecast7   Market
  Breakup by Indication    7.1    Open Angle
  Glaucoma        7.1.1 Market Trends       
  7.1.2 Market Forecast    7.2    Angle Closure
  Glaucoma        7.2.1 Market Trends       
  7.2.2 Market Forecast    7.3    Others       
  7.3.1 Market Trends        7.3.2 Market
  Forecast8   Market Breakup by End User    8.1  
   Hospitals        8.1.1 Market Trends       
  8.1.2 Market Forecast    8.2    Ophthalmic
  Clinics        8.2.1 Market Trends        8.2.2
  Market Forecast    8.3    Ambulatory Surgery
  Centers        8.3.1 Market Trends        8.3.2
  Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/glaucoma-therapeutics-market/toc

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com